This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Nov 22;7(12):657.

doi: 10.1038/nrneurol.2011.184.

Multiple sclerosis: Teriflunomide shows promise for MS treatment in phase III trial

PMID: 22105215
DOI: 10.1038/nrneurol.2011.184

Comment

Multiple sclerosis: Teriflunomide shows promise for MS treatment in phase III trial

Heather Wood. Nat Rev Neurol. 2011.

. 2011 Nov 22;7(12):657.

doi: 10.1038/nrneurol.2011.184.

Author

PMID: 22105215
DOI: 10.1038/nrneurol.2011.184

No abstract available

PubMed Disclaimer

Comment on

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.
O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS; TEMSO Trial Group. O'Connor P, et al. N Engl J Med. 2011 Oct 6;365(14):1293-303. doi: 10.1056/NEJMoa1014656. N Engl J Med. 2011. PMID: 21991951 Clinical Trial.

References

1. Neurology. 2006 Mar 28;66(6):894-900 - PubMed
1. N Engl J Med. 2011 Oct 6;365(14):1293-303 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.